fbpx
Meridian Clinical Research logo in white.

Migraine Headache Study

Now Open in Savannah, GA

Meridian is conducting a clinical trial for an investigational migraine medication. Migraines are usually accompanied by moderate to severe headaches, nausea, and hypersensitivity to light and sound. Attacks generally last between 4 and 72 hours, and can place a significant burden on work, family, and quality of life.

If you frequently experience migraines, you may be eligible to join this clinical trial.

Eligible participants…

  • Must be age 18 to 75
  • Must experience 4 to 15 migraines per month
  • Must have experienced migraines for at least a year before joining the study
  • May qualify for compensation. Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.


Study Location(s)

Meridian Clinical Research
6602 Waters Avenue, Building C
Savannah, GA 31406

Submit Your Information

About Meridian Clinical Research

Founded in 1999, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services.

Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.

© 2018 MERIDIAN CLINICAL RESEARCH | Privacy Policy